Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02110095 · ClinicalTrials.gov registry record · NA

Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos

A NA study, sponsored by Cynosure.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02110095: Completed NA study, sponsored by Cynosure.

NCT02110095 is a NA study that has completed, run by Cynosure. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02110095, a NA study, has completed, sponsored by Cynosure.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the Picosure Laser System for the treatment of unwanted tattoos.

Primary Outcome

Tattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale. The scale ranges from 0 to 10, where 10 is 100% improvement from the baseline photo.

Interventions

  • DEVICE Picosure Laser System

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-01
Est. Completion 2016-11
Phase NA
Cynosure

49 total trials

What the finished NCT02110095 record still lists

NCT02110095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Picosure Laser System is the first listed.

NCT02110095 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02110095 about?

NCT02110095 is a clinical study titled "Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos". The purpose of this study is to evaluate the Picosure Laser System for the treatment of unwanted tattoos.

What is the current status of trial NCT02110095?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-01. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02110095?

The interventions under investigation include: Picosure Laser System (DEVICE).

Who is sponsoring clinical trial NCT02110095?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02110095's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02110095, the US trial registry maintained by the National Library of Medicine. NCT02110095 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.